UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 620

Sortiert nach

Refined Analysis of Prostate-specific Antigen Kinetics to Predict Prostate Cancer Active Surveillance Outcomes

European urology, 2018-08, Vol.74 (2), p.211-217

2018

Volltextzugriff (PDF)

A regionally tailored epidemiological forecast and monitoring program to guide a healthcare system in the COVID-19 pandemic

Journal of infection and public health, 2024-06, Vol.17 (6), p.1125-1133

2024

Volltextzugriff (PDF)

Systematic review of reported association studies of monogenic genes and bladder cancer risk and confirmation analysis in a large population cohort

BJUI compass, 2023-03, Vol.4 (2), p.156-163

2023

Volltextzugriff (PDF)

Epidemiology and survival outcome of adult kidney, bladder, and prostate rhabdomyosarcoma: A SEER database analysis

Rare tumors, 2020, Vol.12, p.2036361320977401-2036361320977401

2020

Volltextzugriff (PDF)

Pediatric robotic urologic surgery-2014

Journal of Indian Association of Pediatric Surgeons, 2014-07, Vol.19 (3), p.123-128

2014

Volltextzugriff (PDF)

Corrigendum re: “Associations Between iCOGS Single Nucleotide Polymorphisms and Upgrading in Both Surgical and Active Surveillance Cohorts of Men with Prostate Cancer” [Eur Urol 2016;69:223–8]

European urology, 2016-09, Vol.70 (3), p.e90-e90

Kearns, James T

2016

Volltextzugriff (PDF)

PSA screening, prostate biopsy, and treatment of prostate cancer in the years surrounding the USPSTF recommendation against prostate cancer screening

Cancer, 2018-07, Vol.124 (13), p.2733-2739

2018

Volltextzugriff (PDF)

Is Active Surveillance Too Active?

Current urology reports, 2023-10, Vol.24 (10), p.463-469

2023

Volltextzugriff (PDF)

Improving the Specificity of PSA Screening with Serum and Urine Markers

Current urology reports, 2018-10, Vol.19 (10), p.80-80, Article 80

2018

Volltextzugriff (PDF)

Reply to Runqiang Yuan's Letter to the Editor re: James T. Kearns, Anna V. Faino, Lisa F. Newcomb, et al. Role of Surveillance Biopsy with No Cancer as a Prognostic Marker for Reclassification: Results from the Canary Prostate Active Surveillance Study. Eur Urol 2018;73:706–12

European urology, 2018-12, Vol.74 (6), p.e151-e151

2018

Volltextzugriff (PDF)

Racial Disparities in Prostate Specific Antigen Screening and Referral to Urology in a Large, Integrated Health Care System: A Retrospective Cohort Study

The Journal of urology, 2021-08, Vol.206 (2), p.101097JU0000000000001763-278

2021

Volltextzugriff (PDF)

Prostate cancer screening: Do guidelines matter?

Cancer, 2016-12, Vol.122 (24), p.3760-3761

2016

Volltextzugriff (PDF)

Racial and Socioeconomic Disparities in MRI-Fusion Biopsy Utilization to Assess for Prostate Cancer

Urology (Ridgewood, N.J.), 2022-05, Vol.163, p.156-163

2022

Volltextzugriff (PDF)

Moving Prostate Cancer Polygenic Risk Scores from Research Towards Clinical Practice

European urology focus, 2022-07, Vol.8 (4), p.913-915

2022

Volltextzugriff (PDF)

Role of Surveillance Biopsy with No Cancer as a Prognostic Marker for Reclassification: Results from the Canary Prostate Active Surveillance Study

European urology, 2018-05, Vol.73 (5), p.706-712

2018

Volltextzugriff (PDF)

Associations Between iCOGS Single Nucleotide Polymorphisms and Upgrading in Both Surgical and Active Surveillance Cohorts of Men with Prostate Cancer

European urology, 2016-02, Vol.69 (2), p.223-228

2016

Volltextzugriff (PDF)

Prediction models for prostate cancer outcomes: what is the state of the art in 2017?

Current opinion in urology, 2017-09, Vol.27 (5), p.469-474

2017

Volltextzugriff (PDF)

Continued 5α-Reductase Inhibitor Use after Prostate Cancer Diagnosis and the Risk of Reclassification and Adverse Pathological Outcomes in the PASS

The Journal of urology, 2019-01, Vol.201 (1), p.106-112

2019

Volltextzugriff (PDF)

Is there a benefit to adjuvant radiation in stage III penile cancer after lymph node dissection? Findings from the National Cancer Database

Urologic oncology, 2018-03, Vol.36 (3), p.92.e11-92.e16

2018

Volltextzugriff (PDF)

Pathologic Nodal Involvement in Patients With Penile Cancer With Cavernosal Versus Spongiosal Involvement

Clinical genitourinary cancer, 2019-02, Vol.17 (1), p.e156-e161

2019

Volltextzugriff (PDF)

The development and comparative effectiveness of a patient-centered prostate biopsy report: a prospective, randomized study

Prostate cancer and prostatic diseases, 2020-03, Vol.23 (1), p.144-150

2020

Volltextzugriff (PDF)

Prognostic value of galectin-1 and galectin-3 expression in localized urothelial bladder cancer

Translational andrology and urology, 2023-02, Vol.12 (2), p.228-240

2023

Volltextzugriff (PDF)

EDITORIAL COMMENT

Urology (Ridgewood, N.J.), 2022-03, Vol.161, p.57-58

Kearns, James T

2022

Volltextzugriff (PDF)

Urodynamic studies in spinal cord tethering

Child's nervous system, 2013-09, Vol.29 (9), p.1589-1600

2013

Volltextzugriff (PDF)

Genomic analysis of response to bacillus Calmette-Guérin (BCG) treatment in high-grade stage 1 bladder cancer patients

Translational andrology and urology, 2021-07, Vol.10 (7), p.2998-3009

2021

Volltextzugriff (PDF)

1 – 25 von 620

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(447)
Mit Volltextzugriff
(513)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

Refined Analysis of Prostate-specific Antigen Kinetics to Predict Prostate Cancer Active Surveillance Outcomes

A regionally tailored epidemiological forecast and monitoring program to guide a healthcare system in the COVID-19 pandemic

Systematic review of reported association studies of monogenic genes and bladder cancer risk and confirmation analysis in a large population cohort

Epidemiology and survival outcome of adult kidney, bladder, and prostate rhabdomyosarcoma: A SEER database analysis

Pediatric robotic urologic surgery-2014

Corrigendum re: “Associations Between iCOGS Single Nucleotide Polymorphisms and Upgrading in Both Surgical and Active Surveillance Cohorts of Men with Prostate Cancer” [Eur Urol 2016;69:223–8]

PSA screening, prostate biopsy, and treatment of prostate cancer in the years surrounding the USPSTF recommendation against prostate cancer screening

Is Active Surveillance Too Active?

Improving the Specificity of PSA Screening with Serum and Urine Markers

Reply to Runqiang Yuan's Letter to the Editor re: James T. Kearns, Anna V. Faino, Lisa F. Newcomb, et al. Role of Surveillance Biopsy with No Cancer as a Prognostic Marker for Reclassification: Results from the Canary Prostate Active Surveillance Study. Eur Urol 2018;73:706–12

Racial Disparities in Prostate Specific Antigen Screening and Referral to Urology in a Large, Integrated Health Care System: A Retrospective Cohort Study

Prostate cancer screening: Do guidelines matter?

Racial and Socioeconomic Disparities in MRI-Fusion Biopsy Utilization to Assess for Prostate Cancer

Moving Prostate Cancer Polygenic Risk Scores from Research Towards Clinical Practice

Role of Surveillance Biopsy with No Cancer as a Prognostic Marker for Reclassification: Results from the Canary Prostate Active Surveillance Study

Associations Between iCOGS Single Nucleotide Polymorphisms and Upgrading in Both Surgical and Active Surveillance Cohorts of Men with Prostate Cancer

Prediction models for prostate cancer outcomes: what is the state of the art in 2017?

Continued 5α-Reductase Inhibitor Use after Prostate Cancer Diagnosis and the Risk of Reclassification and Adverse Pathological Outcomes in the PASS

Is there a benefit to adjuvant radiation in stage III penile cancer after lymph node dissection? Findings from the National Cancer Database

Pathologic Nodal Involvement in Patients With Penile Cancer With Cavernosal Versus Spongiosal Involvement

The development and comparative effectiveness of a patient-centered prostate biopsy report: a prospective, randomized study

Prognostic value of galectin-1 and galectin-3 expression in localized urothelial bladder cancer

EDITORIAL COMMENT

Urodynamic studies in spinal cord tethering

Genomic analysis of response to bacillus Calmette-Guérin (BCG) treatment in high-grade stage 1 bladder cancer patients

Suchergebnisse filtern